NCT00904852 2009-05-20Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma MultiformeMillennium Pharmaceuticals, Inc.Phase 1 Withdrawn30 enrolled